TTP plc
TTP plc is an independent UK technology and product development consultancy with 300+ multidisciplinary engineers and scientists, delivering full-lifecycle product development across medical devices, drug delivery, satellite communications, defence, and deep tech for enterprise clients including AstraZeneca, Roche, Medtronic, and Viasat.
- Company typePrivate
- Founded1986
- HeadquartersMelbourn, United Kingdom
- Headcount251–500
- GTM typeB2B
- OfferingServices
What TTP plc does
TTP plc is an independent UK technology and product development consultancy founded in 1986 and headquartered at its campus in Melbourn, Cambridgeshire, with a US operation in Boston led by Harry Bullivant. The firm employs over 300 engineers, scientists, and human factors specialists within its MedTech team alone, supported by a wider staff of 251-500, and delivers multidisciplinary product development services across seven focus areas: Deep Tech (AI, quantum, autonomy, UAVs), Defence (military communications, attritable systems, situational awareness, sovereign solutions), Energy & Industrials, In Vitro Diagnostics, Life Sciences, Medical Devices & Drug Delivery, and Satellite & Space. TTP is privately held under TTP Group Ltd despite its UK plc designation, and operates a sales-led, project-based consulting model that engages directly with enterprise clients from concept through manufacturing transfer, without disclosed pricing or product resale channels.
TTP's core technical platform spans mechanical, electrical, software, RF, and human factors engineering, with proprietary assets including Software Defined Ultrasound (SDU), closed-loop neuromodulation systems built on Velocity Selective Recording (VSR) techniques developed with the University of Bath, software-defined radio platforms supporting multi-orbit 5G NTN, implantable CGM sensors with BLE connectivity, and edge-deployed CNN-based passive RF drone detection with synthetic data pipelines. High-impact client deliverables include the AstraZeneca Symbicort dose counter (FDA-approved on first submission, supporting a downstream product exceeding $2B in annual revenue), the CoVent ventilator developed with Dyson during COVID-19 (MHRA-ready design delivered in one month), and the Spectra Group GENSS tactical radio family (commercialised within 18 months of feasibility study). The firm's revenue is generated through professional services fees on multi-year engagements; named enterprise customers include AstraZeneca, Roche, Medtronic, Novartis (Gyroscope), 3M, Hovione, Dyson, Viasat, Thales, ESA, Spectra Group, and Omnispace, alongside recurring startup engagements (GlucoTrack, Carbometrics, ACT Medical, Serac Imaging, Prolight Diagnostics) and an active spin-out pipeline exemplified by LEX Diagnostics.
TTP plc firmographics
Firmographics- Name
- TTP plc
- Legal name
- TTP plc
- Website
- https://ttp.com
- Company type
- Private
- Founded year
- 1986
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- TTP plc is an independent UK technology and product development consultancy with 300+ multidisciplinary engineers and scientists, delivering full-lifecycle product development across medical devices, drug delivery, satellite communications, defence, and deep tech for enterprise clients including AstraZeneca, Roche, Medtronic, and Viasat.
- Ownership category
- akta.pro rank
TTP plc industry classification
Industry- Product category
- Technology and Product Development Consulting
- NAICS
- Other Computer Related Services (541519)
- SIC
- Services-Computer Integrated Systems Design (7373)
- akta.pro primary industry
- Process Development & Tech Transfer Services (CDMO) (HLAGABAL)
- akta.pro secondary industry
- C4ISR Systems & Tactical Data Links (IMABAGAE)
Keywords
Where TTP plc is headquartered
LocationHeadquarters
- HQ city
- Melbourn
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
TTP plc business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Technology and Product Development Consulting: TTP operates as an independent technology and product development consultancy. They provide project-based development services where multidisciplinary teams work with clients on complex technology challenges from concept through to manufacturing. Revenue is generated through consulting fees and project engagements rather than product sales.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
TTP plc product offering
Product offeringCore offering
TTP plc is an independent technology and product development consultancy providing multidisciplinary engineering teams to solve complex technology challenges. They deliver end-to-end product development services—from concept through prototyping, regulatory, and manufacturing transfer—across sectors including medical devices, drug delivery, neurotechnology, defence communications, satellite systems, UAVs, AI, quantum technologies, and in vitro diagnostics.
Product overview
TTP plc is an independent technology and product development consultancy with nearly 40 years of experience, offering a broad portfolio of services across multiple sectors. The company operates as a multi-disciplinary consultancy rather than a single unified product, providing expertise in deep tech (AI, quantum, autonomy, UAVs), defence (military communications, attritable systems, situational awareness, sovereign solutions), energy & industrials, medical devices & drug delivery, in vitro diagnostics, life sciences, and satellite & space communications. Key service offerings include AI consultancy, biosensor development, neurotechnology device development, drug delivery systems, surgical devices, medical imaging, cell & gene therapy manufacturing, satellite terminals, and 5G NTN solutions. The company also develops proprietary platforms including Software Defined Ultrasound (SDU) and closed-loop neuromodulation systems. With over 300 engineers, scientists, and human factors specialists based at their Cambridge campus, TTP works with clients across the full product development lifecycle from concept to manufacture.
Differentiator
Problem solved
Functional benefit
Products and services
- AI Consultancy & Implementation Consultancy services helping clients exploit AI in cyber-physical systems, from strategy to implementation for AI-powered products and systems.
- Quantum Technologies Consulting Expertise in quantum technologies including quantum sensors, quantum computing applications, and quantum-safe communications for clients exploring quantum advantages.
- UAV Technology Solutions Complete technology solutions for autonomous flight beyond visual line of sight (BVLoS), including detect-and-avoid systems, communications, and safety subsystems for UAV operations.
- 5G Non-Terrestrial Network Solutions Expertise in converging terrestrial and satellite communications, including direct-to-device satellite connectivity, multi-orbit solutions, and 5G NTN terminal development.
- Biosensor Device Development Engineering next-generation biosensors from concept to commercialisation, including wearable and implantable devices for continuous glucose monitoring, neural sensing, and other applications.
- Neurotechnology Device Development Deep neurotechnology expertise for developing neuromodulation devices including closed-loop systems, neural implants, and brain-computer interfaces for conditions such as Parkinson's, epilepsy, and chronic pain.
- Drug Delivery Device Development Design and engineering expertise in advanced drug delivery systems including inhalers, injectables, ocular delivery, and implantable drug delivery devices.
- Surgical Device Design & Development Surgical and minimally invasive product design and development for complex clinical challenges, including surgical robotics and precision surgical tools.
- In Vitro Diagnostics System Development Diagnostic innovation acceleration from concept to product, including immunoassay systems, molecular diagnostics, and point-of-care testing platforms.
- Satellite Terminal Development Innovative satellite terminals, core terminal technology, and antennas for networks, applications, and environments including handheld, vehicle-mounted, and fixed installations.
- Software Defined Ultrasound (SDU) Platform Flexible platform for accelerating ultrasound product development, modular software architecture enabling customisation and rapid product development.
- Low-Cost Handheld Drone Detection System Pocket-sized passive RF drone detector using edge AI and machine learning for counter-UAS applications, designed for tactical, civilian, and infrastructure security deployments.
Quantifiable outcome
- Developed AstraZeneca's Symbicort dose counter - FDA approved on first submission with annual revenues exceeding $2 billion
- +3 more outcomes
Companies that use TTP plc
Customer profileNamed customers15 records
Segments7 records
Ideal customer profiles4 records
TTP plc technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability10 records
Feature6 records
TTP plc partnerships and signals
Strategic signalPartnerships
24 partnerships are on record, tiered core and minor.
- Viasat Inc.coreCollaboration under ESA Iris programme for BVLOS flight trials testing multi-link connectivity technologies for uncrewed aircraft operations. TTP contributes to integrated connectivity demonstrations showing how satellite and terrestrial networks support trusted information exchange with UTM systems.
- ThalescorePartnership in ESA Iris RPAS programme for BVLOS connectivity demonstrations using National Flying Laboratory Centre's Bulldog aircraft. Testing multi-link connectivity combining satellite, cellular, and C-band radio for safe uncrewed aircraft operations.
- European Space Agency (ESA)coreESA Iris programme partnership for developing trusted multi-link communications enabling BVLOS uncrewed aviation operations. TTP contributes technical expertise in connectivity and satellite communications.
- DimetorcorePartner in ESA Iris RPAS programme contributing to multi-link connectivity solutions for BVLOS UAV operations and UTM integration.
- GlucoTrackcorePartnership for implantable continuous glucose monitoring technology development. Peer-reviewed study published in IEEE Sensors Journal supports feasibility of long-life implantable CGMs.
- Cellular OriginsminorBoth mentioned as companies responding to CGT manufacturing scaling challenges through robotic automation and digital systems.
- MetalysiscoreConsortium partner in ESA-funded 24-month project to scale sustainable titanium production using Metalysis FFC process. TTP contributes expertise to establish secure Western supply chain for titanium.
- Lucideon LtdminorConsortium partner in ESA titanium production project alongside Metalysis, TTP, NCHG Ltd, and RHP-Technology GmbH.
- RHP-Technology GmbHminorAustrian consortium partner in ESA titanium production project focused on scaling Metalysis FFC process for sustainable titanium.
- NCHG LtdminorUK consortium partner in ESA titanium production project for sustainable titanium manufacturing.
- OmnispacecoreStrategic agreement for satellite-based IoT and 5G services developing global hybrid 5G non-terrestrial network using standards-based 3GPP compliance.
- C3Bio / University of BathcoreCollaboration with Centre for Biosensors, Bioelectronics and Biodevices at University of Bath to implement velocity selective recording techniques for next-generation neuromodulation therapy products.
- Spectra Group (UK)coreDeveloped GENSS family of tactical radio products - created bespoke SDR platform for data-centric beyond-line-of-sight communications within 1.5 years from initial feasibility study.
- Terrestar SolutionscoreDeveloped 5G NTN antenna for Sat Companion enabling direct-to-mobile 5G NTN connectivity while meeting stringent SAR regulations.
- AstraZenecacoreLong-term partnership developing dose counter for Symbicort inhaler - FDA approved on first submission. Annual revenues for Symbicort exceed $2 billion.
- Roche DiagnosticscoreManufacturing engineering collaboration - developed test beds for modelling processes and verified solutions without full-scale pilots.
- MedtroniccoreCollaboration on neuromodulation and neuroscience therapies.
- DysoncorePartnership to develop CoVent ventilator for UK NHS during COVID-19 pandemic - delivered MHRA-ready design in one month.
- HovionecoreTwinCaps dry powder inhaler development partnership - product became best-selling disposable inhaler.
- 3McoreDesigned commercial-ready applicator for 3M's hollow microneedle array for clinical work.
- Ripple TherapeuticscoreDe-risked drug injection device concepts for ocular drug delivery - analysis steered away from costly-to-prove reliability concepts.
- Gyroscope (Novartis)coreRefined fluidic control elements of Orbit SDS device for microinjection into the eye for dry AMD treatment.
- CarbometricscorePrototype sensing membranes development for Continuous Glucose Monitoring sensors using biomimetic glucose binding molecules.
- Frequentis AGcorePartner in ESA Iris programme for BVLOS flight trials under European Space Agency programme.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
TTP plc competitors and assessment
Company assessmentDirect peers
- Cambridge Consultants: UK-based multidisciplinary product development consultancy with comparable breadth across medical devices, defence, wireless, and industrial. Cambridge Consultants is TTP's closest structural peer with overlapping capabilities in neurotechnology, drug delivery, and SDR.
- Battelle: Large multidisciplinary R&D organisation with defence, life sciences, and energy portfolios. Comparable to TTP in the breadth of applied science and engineering services, particularly in biosensors and national security.
- SRI International: Non-profit R&D institute spanning biosciences, engineering, and defence. Comparable in applied multidisciplinary research with commercial spin-out model similar to TTP's LEX Diagnostics track.
- Plextek: UK-based electronics and RF design consultancy with deep expertise in SDR, sensors, and defence communications. Highly comparable to TTP's military comms, UAV connectivity, and bespoke radio platform work.
- Sagentia Innovation: UK-headquartered technology and product development consultancy serving medical, industrial, and consumer markets. Comparable in sector breadth and client base (especially MedTech and diagnostics) with similar fee-for-service engagement model.
- PA Consulting: Global innovation and engineering consultancy with deep MedTech, aerospace, and defence practices. Overlaps with TTP across medical device development, drug delivery, and digital health transformation engagements.
- Ximedica: US medical device design and development firm focused on diagnostics, drug delivery, and surgical devices. Comparable MedTech vertical with similar client mix of large OEMs and venture-backed startups.
- StarFish Medical: Medical device design and development consultancy serving North American clients. Directly comparable to TTP's MedTech practice (biosensors, surgical devices, imaging, drug delivery) though geographically focused on Canada/US.
Broad incumbents
- Capgemini Engineering: Global engineering services arm of Capgemini with embedded software, systems engineering, and digital twin practices. Broader incumbent competing for large multi-year digital transformation and engineering programmes TTP serves.
- Phillips Medisize: Global medical device design, development, and manufacturing services provider. Overlaps with TTP's drug delivery device development and biosensor programmes but with integrated manufacturing at much larger scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
TTP plc social profiles
Digital presenceTTP plc financial estimates
Financial estimateRevenue estimate
Valuation estimate
TTP plc leadership team
Management profileNumber of profiles
Profiles10 records
TTP plc funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TTP plc M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TTP plc
What does TTP plc do?
TTP plc is an independent technology and product development consultancy providing multidisciplinary engineering teams to solve complex technology challenges. They deliver end-to-end product development services—from concept through prototyping, regulatory, and manufacturing transfer—across sectors including medical devices, drug delivery, neurotechnology, defence communications, satellite systems, UAVs, AI, quantum technologies, and in vitro diagnostics.
Is TTP plc a public or private company?
TTP plc is a private company. It is classified as corporate owned and is currently operating.
When was TTP plc founded?
TTP plc was founded in 1986. It employs 251 to 500 people.
Where is TTP plc based?
TTP plc is headquartered in Melbourn, United Kingdom, in the Europe region.
How does TTP plc make money?
One revenue line is on record: technology and Product Development Consulting.
Who are TTP plc's main competitors?
Direct peers on record are Cambridge Consultants, Battelle, SRI International, Plextek, Sagentia Innovation, PA Consulting, Ximedica and StarFish Medical. Broad incumbents are Capgemini Engineering and Phillips Medisize.
Does TTP plc have an API?
No public API is recorded for TTP plc.
What industry is TTP plc in?
TTP plc's product category is Technology and Product Development Consulting. Its primary akta.pro industry code is HLAGABAL, Process Development & Tech Transfer Services (CDMO), with a secondary code of IMABAGAE, C4ISR Systems & Tactical Data Links. Its NAICS code is 541519 and its SIC code is 7373.